Who owns Alnylam Pharmaceuticals (ALNY)? Superinvestor holders

4 superinvestors of the 157 tracked here hold Alnylam Pharmaceuticals (ALNY) in their latest 13F filing, with $2.2B between them. Baillie Gifford team gives it the most weight: 1.28% of the reported portfolio. In their latest reported quarter, Baillie Gifford team, Dodge & Cox team and David Shaw (founder) added; Ray Dalio (founder) reduced.

Ken Fisher sold out of it in their latest quarter.

Hold it now
4
of 157 tracked
Combined value
$2.2B
Bought / sold
3 / 2
last quarter

Key facts

Superinvestors holding it
4 of 157
Biggest holder
Baillie Gifford team, $1.4B
Largest weight
Baillie Gifford team, 1.28%of their portfolio
Combined value
$2.2B
Bought last quarter
3
Sold last quarter
2

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding ALNY, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Baillie Gifford teamBaillie Gifford & Co1.28%$1.4B5.49M▲ Added 125%+3.05MQ3 2026
2Dodge & Cox teamDodge & Cox0.27%$495.1M2.01M▲ Added 2.6%+51.04KQ3 2026
3David Shaw (founder)D. E. Shaw & Co.0.21%$332.4M1.1M▲ Added 4.3%+45.01KQ2 2026
4Ray Dalio (founder)Bridgewater Associates0.12%$30M99.58K▼ Reduced 6.6%−7KQ2 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of ALNY by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269227.5M$1.9B21
Q2 202615757.47M$2.3B23
Q1 202615757.58M$2.5B33
Q4 202515766.63M$2.6B43
Q3 202515757M$3.2B32
Q2 202515757.77M$2.5B33
Q1 202515658.2M$2.2B32
Q4 202415638.39M$2B12

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of ALNY held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Baillie Gifford team5.49M2.44M2.49M2.6M2.79M3.03M3.66M4.04M
Dodge & Cox team2.01M1.96M1.93M1.96M2.32M3.2M3.35M3.54M
John Overdeck and David Siegel (founders)—1.88M1.99M616.12K595.93K343.31K——
David Shaw (founder)·1.1M1.06M444.49K————
Ray Dalio (founder)·99.58K106.59K85.62K————
Cliff Asness·——919.96K744.01K—828.34K813.36K
Israel Englander·———549.93K———
Ken Griffin·————601.2K——
Brandon Haley·————596.82K——
Steve Cohen·—————300.64K—
George Soros——————60K—

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own ALNY?

In their latest 13F filings: Baillie Gifford team (1.28% of the portfolio, $1.4B), Dodge & Cox team (0.27% of the portfolio, $495.1M), David Shaw (founder) (0.21% of the portfolio, $332.4M), Ray Dalio (founder) (0.12% of the portfolio, $30M).

Who bought ALNY last quarter?

Baillie Gifford team (added 125%), Dodge & Cox team (added 2.6%), David Shaw (founder) (added 4.3%). “Last quarter” is each investor's latest reported quarter.

Who sold ALNY last quarter?

Reduced: Ray Dalio (founder) (6.6% fewer shares). Sold out entirely: Ken Fisher (was $1.9M).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns Alnylam Pharmaceuticals (ALNY)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/ALNY/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to ALNY by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.